Pfizer
PFE
PFE
1,987 hedge funds and large institutions have $152B invested in Pfizer in 2016 Q2 according to their latest regulatory filings, with 125 funds opening new positions, 818 increasing their positions, 836 reducing their positions, and 83 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,987
Holders Change
+24
Holders Change %
+1.22%
% of All Funds
53.1%
Holding in Top 10
285
Holding in Top 10 Change
+84
Holding in Top 10 Change %
+41.79%
% of All Funds
7.62%
New
125
Increased
818
Reduced
836
Closed
83
Calls
$2.54B
Puts
$2.54B
Net Calls
-$1.2M
Net Calls Change
+$286M
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$2.37B |
| 2 |
Royal London Asset Management
United Kingdom
|
-$1.46B |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$943M |
| 4 |
CM
Corvex Management
New York
|
-$520M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$480M |